Partnership Opportunities
Looking To Position Yourself as a Leader Within the Gene Therapy Space?
Delivery, delivery, delivery: the three biggest current challenges facing early-stage gene therapy developers. The future clinical success of gene therapies relies on current innovation in capsid and payload design to improve the next generation of delivery platforms.
While innovation in industry is high, their clarity over who stand out as the leading service providers able to help their vector development work is low.
Our senior biopharma audience want to hear from you if your services can add value to conversations around:
Vector synthesis capabilities, with reliable fast turnarounds to support custom viral vector production
Reagent provisions such as transfection and transduction reagents, buffers, and cultures
Synthetic and computational based tools to improve vector design and candidate selection
CDMOs with reliable and scalable platforms, cable of robustly incorporating novel molecules into their workflows
... and more!
In return, we can provide you with a unique platform to showcase your capabilities, helping you establish a new network of potential clients and ultimately establish a competitive edge.
If you work to support gene therapy vector developers and are looking to establish yourself as a market leader, this is the one meeting in 2024 you need to partner with.
